The VA considers GLP-1s for weight loss non-formulary medications, meaning healthcare providers must submit exception requests in order for the drug to be dispensed for the purpose of weight loss
Until relatively recently, scientists viewed obesity as a single disease, but now experts around the world have begun to realise that it is far more complex
Beyond this drug class, NICE guideline NG28 for type 2 diabetes management recommends various alternatives including: SGLT2 inhibitors such as dapagliflozin or empagliflozin, which offer cardiovascular and renal protective benefits DPP-4 inhibitors like sitagliptin, which have a favourable side effect profile Traditional agents including metformin, sulphonylureas, or insulin therapy, depending on disease progression and individual circumstances When preparing to discuss concerns about Ozempic with your GP, it is helpful to document specific symptoms, their timing in relation to doses, their impact on daily activities, and any measures already attempted to manage them
& Schweizer, A
The good news is that GLP-1 receptor agonists can be safely used in people with high blood pressure, and evidence suggests they may offer additional benefits for blood pressure control
